For the first time, a non-pharmaceutical clinical trial has proven effective in reversing the main activators of Alzheimer’s disease, according to Tel Aviv University’s Prof. Shai Efrati, whose study on the use of hyperbaric oxygen therapy (HBOT) to improve brain function was published Thursday in the peer-reviewed medical journal Aging.
The study, which combined use of HBOT in the treatment of animals genetically engineered to develop Alzheimer’s and a group of individuals over the age of 65 who were already experiencing memory decline – the stage before Alzheimer’s – yielded several positive results. These included improvement in vascular function, of blood flow to the brain, memory capacity, attention and information processing speed, as well as a drop in brain amyloid load.
From an article in the Jerusalem Post
Read the rest of the article here
Introducing our new collection of Botanical Jewelry
Make your shopping in our store today!
